Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

NCT00988598 ·Status: COMPLETED ·Phase: PHASE1

Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

NCT05811442 ·Status: COMPLETED ·Phase: PHASE2

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

NCT00141661 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)

NCT06402838 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

NCT01626391 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 ·Status: COMPLETED ·Phase: PHASE2

Rivastigmine Mini-Tablet for Alzheimer's Disease

NCT06828289 ·Status: NOT_YET_RECRUITING

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

NCT04079803 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

NCT00663936 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

NCT00566397 ·Status: COMPLETED ·Phase: PHASE2

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

NCT01569516 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01028911 ·Status: TERMINATED ·Phase: PHASE1

A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

NCT00455000 ·Status: COMPLETED ·Phase: PHASE1

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

NCT00810147 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

NCT06702124 ·Status: RECRUITING ·Phase: PHASE3

A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease

NCT02260674 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease

NCT06840054 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

NCT02711683 ·Status: COMPLETED

Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age

NCT02576639 ·Status: COMPLETED ·Phase: PHASE2

A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants

NCT04023994 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

NCT00100334 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of LM11A-31-BHS in Mild-moderate AD Patients

NCT03069014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

NCT01969123 ·Status: TERMINATED ·Phase: PHASE3

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

NCT01969136 ·Status: TERMINATED ·Phase: PHASE3